📰 Source: arstechnica | Ars Technica - All content

✍️ Original author: Sara Talpos, Undark Magazine

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

This post was automatically imported by OratioRepostBot.